How Investors May Respond To Church & Dwight (CHD) Divesting VMS Brands Amid Softer Value-Segment Demand
Church & Dwight Co., Inc. CHD | 92.85 | 0.00% |
- In recent weeks, Church & Dwight completed a review of its vitamins, minerals, and supplements business and agreed to sell its VitaFusion and L’il Critters brands to Piping Rock Health Products, expecting a one-time after-tax charge of US$40 million to US$45 million in the fourth quarter of 2025.
- At the same time, commentary from Fundsmith Equity Fund highlighted how economic pressures on US consumers are weighing on demand for Church & Dwight’s discount products, raising fresh questions about the resilience of its core customer base.
- We’ll now examine how these consumer-demand pressures, highlighted by Fundsmith, may influence Church & Dwight’s previously outlined investment narrative.
Uncover the next big thing with financially sound penny stocks that balance risk and reward.
Church & Dwight Investment Narrative Recap
To own Church & Dwight today, you need to believe its core household and personal care brands can offset pressure on value-conscious consumers and any portfolio reshaping. The planned sale of VitaFusion and L’il Critters, and the related US$40 million to US$45 million charge in Q4 2025, does not appear to alter the near term demand risk that Fundsmith highlighted as the key issue to watch.
The agreed divestment of Church & Dwight’s vitamins, minerals, and supplements business is the clearest recent announcement tied to this debate, given earlier concerns about underperformance and potential revenue dilution in that segment. While this move may simplify the business mix around core franchises, it also sharpens the focus on how resilient demand will be for Church & Dwight’s remaining discount-oriented products as US consumers stay under pressure.
But while these shifts might look manageable at first glance, investors should still be aware of...
Church & Dwight's narrative projects $6.8 billion revenue and $1.0 billion earnings by 2028. This requires 3.9% yearly revenue growth and about a $474.8 million earnings increase from $525.2 million today.
Uncover how Church & Dwight's forecasts yield a $97.26 fair value, a 11% upside to its current price.
Exploring Other Perspectives
Five fair value estimates from the Simply Wall St Community span roughly US$96 to US$122 per share, showing how far apart views can be. Set those opinions against the current concern about weaker demand for discount products, and you can see why it pays to compare several perspectives on Church & Dwight’s future performance.
Explore 5 other fair value estimates on Church & Dwight - why the stock might be worth as much as 39% more than the current price!
Build Your Own Church & Dwight Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your Church & Dwight research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
- Our free Church & Dwight research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Church & Dwight's overall financial health at a glance.
Looking For Alternative Opportunities?
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
- The latest GPUs need a type of rare earth metal called Dysprosium and there are only 38 companies in the world exploring or producing it. Find the list for free.
- Find companies with promising cash flow potential yet trading below their fair value.
- The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
